COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium.


Journal

Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629

Informations de publication

Date de publication:
06 2021
Historique:
received: 18 02 2021
accepted: 28 02 2021
pubmed: 10 3 2021
medline: 24 6 2021
entrez: 9 3 2021
Statut: ppublish

Résumé

As we pass the nearly 9 month mark of the coronavirus virus disease 2019 (COVID-19) pandemic in the United States, we sought to compile a brief multi-disciplinary compendium of COVID-19 information learned to date. COVID-19 is an active viral pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that confers high morbidity and mortality. COVID-19 has been associated with: pulmonary compromise and acute respiratory distress syndrome, thrombotic events, inflammation and cytokine, and post-infectious syndromes. Mitigation of these complications and expeditious therapy are a global urgency; this is brief summary of current data and management approaches synthesized from publications, experience, cross-disciplinary expertise (Figure 1).

Identifiants

pubmed: 33686384
doi: 10.1016/j.jtct.2021.02.036
pii: S2666-6367(21)00743-0
pmc: PMC7927582
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

474.e1-474.e3

Informations de copyright

© 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Références

JAMA. 2020 May 12;323(18):1839-1841
pubmed: 32215647
JAMA. 2021 Feb 16;325(7):632-644
pubmed: 33475701
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
Lancet Haematol. 2021 Mar;8(3):e185-e193
pubmed: 33482113
JAMA. 2020 Aug 4;324(5):460-470
pubmed: 32492084
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
N Engl J Med. 2021 Jan 7;384(1):20-30
pubmed: 33332779
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831

Auteurs

Kirsten M Williams (KM)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia. Electronic address: Kwill99@emory.edu.

P T Wilson (PT)

Department of Pediatrics, Division of Pediatric Critical Care Medicine, Columbia University Medical Center, New York, New York.

F Silva-Palacios (F)

Vascular Medicine, Cardiovascular Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

J Kebbe (J)

Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

A D LaBeaud (AD)

Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California.

Higuita Agudelo (H)

Section of Infectious Diseases, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma.

R F Sidonio (RF)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.

S R Stowell (SR)

Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia.

C D Josephson (CD)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia.

B A Tarini (BA)

Children's Research Institute, Children's National Hospital, Department of Pediatrics, George Washington University, Washington, DC.

J L Holter Chakrabarty (JL)

Department of Medicine, Division of Hematology/Oncology/Marrow Transplantation and Cell Therapy, University of Oklahoma, Stephenson Cancer Center, Oklahoma City, Oklahoma.

A L Agwu (AL)

Department of Pediatrics and Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH